Healthcare
Hony completes $569m sell down of CSPC Pharma
Hony Capital has made a partial exit from Chinese generic drugs maker CSPC Pharmaceutical Group, generating HK$4.41 billion ($569 million).
Yunfeng raises more than $1b for China fund
Yunfeng Capital, a Chinese PE firm set up by Jack Ma and David Yu, founders of Alibaba Group and Target Media, respectively, has reached a final close of around $1.1 billion on its second fund.
IMC PE unit invests in Singapore's Q&M Dental
Heritas Helios Investments (HHI), a healthcare PE fund seeded by Singaporean conglomerate IMC, has acquired a 10% stake in Q&M Dental Group from existing shareholders for S$30 million ($24 million).
Japan's INCJ joins $8.2m deal for TB vaccine developer
The Innovation Network Corporation of Japan has made a joint investment with Osaka-based Dainippon Sumitomo Pharma and Japan BCG Laboratory in Create Vaccine Company, which is developing a new tuberculosis (TB) vaccine.
Standard Chartered commits $50m to Indonesia hospital business
Standard Chartered Private Equity (SCPE) has agreed to invest up to $50 million to support an Indonesian healthcare business being developed by domestic media giant Emtek Group.
IFC commits $147m to India's Jubilant Pharma
International Finance Corporation (IFC) has completed one of its largest investments in India’s healthcare sector, committing $147.5 million to Jubilant Pharma.
Japan's Next Capital exits massage chair maker to Asahi
Next Capital has agreed to exit its stake in Fuji Medical Instruments (Fujiiryoki), a Japanese manufacturer of massage chairs and other health-related products, to Asahi Holdings for JPY7.8 billion ($76.7 million).
Taiwan's National Development Fund targets tech investments
Taiwan’s National Development Fund has committed NT$1.15 billion ($38 million) to local polysilicon maker Powertec Energy Corporation and a biomedical-focused fund owned by China Development Industrial Bank (CDIB).
Ventureast exits India's Bioserve to Cancer Genetics
US biotech firm Cancer Genetics has acquired India's BioServe Biotechnologies for around $1.9 million, paving an exit for early-stage investor Ventureast.
India cabinet clears KKR for Gland Pharma deal
The Indian government has given KKR the go-ahead to acquire stakes in Gland Pharma and its affiliate Gland Celcus Bio Chemicals in a deal said to be worth around $230 million.
Fosun expresses interest in Australia's Healthscope – report
Fosun Group has highlighted the China growth potential of private equity-owned Australian hospital operator Healthscope, prompting speculation it might bid for the asset.
Life sciences player NuSep gets PE funding for Singapore unit
Xeraya Capital, a life sciences investor controlled by Khazanah Nasional, and PE fund JP Asia Prime Capital have invested S$16 million ($12.8 million) in PrIME Biologics, a subsidiary of NuSep that specializes in therapeutic plasma products.
Olympus leads $65m round for India's DM Healthcare - report
Indian hospital chain Aster DM Healthcare is said to be raising $65 million from existing backers Olympus Capital Asia and India Value Fund Advisors (IVFA).
ADB commits $60m to OrbiMed's second Asia fund
The Asian Development Bank (ADB) is to commit up to $60 million to Orbimed Advisors' second Asian healthcare fund - OrbiMed Asia Partners II.
Kunming Pharma, Ping An PE launch healthcare M&A fund
Shanghai-listed Kunming Pharmaceutical Corp. has partnered with a direct investment arm of Ping An Securities to set up a healthcare-focused M&A fund, with a target of RMB500 million ($80 million).
New Horizon leads $70m Series C for Arrail Dental
New Horizon Capital has led a $70 million Series C round of funding for Arrail Dental Clinic, a Beijing-based dental service provider.
TPG, Fosun raise offer to secure China healthcare take-private
A consortium comprising TPG Capital and Fosun Industrial has agreed to privatize NASDAQ-listed Chinese healthcare provider Chindex International in a deal worth $461 million, after raising its offer to head off competition from a rival financial bidder....
India's SIDBI invests in diabetes hospital
SIDBI Venture Capital has invested INR180 million ($3 million) in the India Kanungo Institute of Diabetes Specialities (KIDS) via its Samridhi Fund.
China online health forum secures $1m from Lightspeed
Lightspeed China Partners has committed $1 million to Kanchufang, a Chinese online healthcare information operator.
TPG, Fosun target Chindex gets better buyout offer
Chindex International has received a take-private offer from an unspecified financial bidder that values the Chinese healthcare provider at around $414 million, exceeding an earlier offer submitted by TPG Capital and Fosun Industrial alongside the CEO....
PE-backed iKang Healthcare jumps 8.6% on US debut
Shares in iKang Healthcare Group – the Chinese healthcare services provider whose backers include GIC Private, Goldman Sachs and NewQuest Asia – climbed 8.6% on their NASDAQ trading debut following a $153 million IPO.
Rabo Equity's India nutrition play
Valued at around INR720 billion ($11.9 billion), India’s pharmaceutical market continues to be a popular destination with private equity investors, but the sector has seen better days. A recent report by PricewaterhouseCoopers shows a tightening regulatory...
China healthcare: Innovation issues
There is plenty of buzz about investment in Chinese healthcare but the pharmaceuticals segment has yet to fulfill its promise as an R&D hub. Should PE and VC investors be looking for different angles?
BVCF raises $200m for third China life sciences fund
BVCF, a China life sciences-focused PE firm, has reached a final close of $200 million on its third fund.